Evidence map›Paper›PMID 30703774›Full record

ReviewHormone research in paediatrics2019

Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up.

Hanneke M van Santen, Marry M van den Heuvel-Eibrink, Marianne D van de Wetering, W Hamish Wallace

Open access · hybridAbstract readReview
In one paragraph

Review in Hormone research in paediatrics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
6.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Low bone mineral density in children and adolescents with cancer.Annals of pediatric endocrinology & metabolism · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Hanneke M van SantenDepartment of Pediatric Endocrinology, Wilhelmina Children's Hospital, UMCU, Utrecht, The Netherlands, h.m.vansanten@umcutrecht.nl.
Marry M van den Heuvel-EibrinkPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
Marianne D van de WeteringPrincess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
W Hamish WallaceDepartment of Paediatric Haematology and Oncology, Royal Hospital for Sick Children, Edinburgh, United Kingdom.
Princess Máxima Center · NLRoyal Hospital for Children · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypogonadism after treatment for childhood cancer is a recognized complication and its cause may be subdivided into primary gonadal failure and central hypogonadism. Here, we provide an overview of the risk factors for the development of hypogonadism, assessment and potential interventions and give a summary of the current recommendations for management and follow-up of hypogonadism in childhood cancer survivors.

Indexed as

Cancer SurvivorsHypogonadismNeoplasmsAdolescentChildChild, PreschoolFemaleHumansInfantMaleChemotherapyHypogonadismLate effectsPremature ovarian failure

Identifiers

PMID30703774
PMCPMC6615280
OpenAlexW2914705205

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.